Repligen Corp. (NASDAQ: RGEN) is -23.15% lower on its value in year-to-date trading and has touched a low of $110.45 and a high of $211.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RGEN stock was last observed hovering at around $144.98 in the last trading session, with the day’s loss setting it -6.81%.
Currently trading at $138.17, the stock is -2.21% and -5.67% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.8 million and changing -4.70% at the moment leaves the stock -14.55% off its SMA200. RGEN registered -9.79% loss for a year compared to 6-month loss of -14.17%. The firm has a 50-day simple moving average (SMA 50) of $146.994 and a 200-day simple moving average (SMA200) of $161.91185.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 1.31% gain in the last 1 month and extending the period to 3 months gives it a 8.26%, and is 1.19% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.86% over the week and 3.66% over the month.
Repligen Corp. (RGEN) has around 1783 employees, a market worth around $7.74B and $602.35M in sales. Fwd P/E is 74.59. Profit margin for the company is -0.32%. Distance from 52-week low is 25.10% and -34.56% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.07%).
Repligen Corp. quarterly earnings per share for the current quarter are estimated at 0.33 with sales reaching $153.23M over the same period.The EPS is expected to shrink by -17.69% this year, but quarterly earnings will post -1.50% year-over-year.
649.0 institutions hold shares in Repligen Corp. (RGEN), with institutional investors hold 112.16% of the company’s shares. The shares outstanding are 55.77M, and float is at 52.09M with Short Float at 7.30%. Institutions hold 104.84% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 7.57 million shares valued at $954.08 million. The investor’s holdings represent 13.5432 of the RGEN Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.07 million shares valued at $638.67 million to account for 9.0659 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 4.61 million shares representing 8.2464 and valued at over $580.94 million, while STATE STREET CORP holds 3.109 of the shares totaling 1.74 million with a market value of $219.02 million.
Repligen Corp. (RGEN) Insider Activity
The most recent transaction is an insider sale by Hunt Anthony, the company’s Director. SEC filings show that Hunt Anthony sold 22,191 shares of the company’s common stock on Sep 10 ’24 at a price of $145.37 per share for a total of $3.23 million. Following the sale, the insider now owns 0.14 million shares.
Still, SEC filings show that on Aug 02 ’24, KURIYEL RALF (Senior VP, R&D) disposed off 7,148 shares at an average price of $159.35 for $1.14 million. The insider now directly holds 12,288 shares of Repligen Corp. (RGEN).
